(Q33408167)

26 July 2017

Role of IL28B and inosine triphosphatase polymorphisms in the treatment of chronic hepatitis C virus genotype 6 infection (English)

1 reference

26 July 2017

1 reference

1 reference

1 reference

1 reference

W-K Seto

1

1 reference

26 July 2017

O T-Y Tsang

2

1 reference

26 July 2017

K Liu

3

1 reference

26 July 2017

J M-C Chan

4

1 reference

26 July 2017

D K-H Wong

5

1 reference

26 July 2017

J Fung

6

1 reference

26 July 2017

C-L Lai

7

1 reference

26 July 2017

M-F Yuen

8

1 reference

26 July 2017

12 April 2013

1 reference

Journal of Viral Hepatitis

26 July 2017

1 reference

26 July 2017

20

1 reference

26 July 2017

7

1 reference

26 July 2017

470-477

1 reference

Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6.

26 July 2017

1 reference

Natural history of chronic hepatitis C: genotype 1 versus genotype 6.

21 January 2018

1 reference

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

21 January 2018

1 reference

Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin.

21 January 2018

1 reference

Chronic hepatitis C genotype 6 responds better to pegylated interferon and ribavirin combination therapy than genotype 1.

21 January 2018

1 reference

Randomized controlled trial of pegylated interferon-alfa 2a and ribavirin in treatment-naive chronic hepatitis C genotype 6.

21 January 2018

1 reference

A randomized trial of 48 versus 24 weeks of combination pegylated interferon and ribavirin therapy in genotype 6 chronic hepatitis C.

21 January 2018

1 reference

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

21 January 2018

1 reference

IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C.

21 January 2018

1 reference

An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response

21 January 2018

1 reference

IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection

21 January 2018

1 reference

Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C

21 January 2018

1 reference

Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection

21 January 2018

1 reference

Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.

21 January 2018

1 reference

ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C.

21 January 2018

1 reference

Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction

21 January 2018

1 reference

Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients

21 January 2018

1 reference

ITPA gene variant protects against anemia induced by pegylated interferon-α and ribavirin therapy for Japanese patients with chronic hepatitis C.

21 January 2018

1 reference

Relationship between polymorphisms of the inosine triphosphatase gene and anaemia or outcome after treatment with pegylated interferon and ribavirin

21 January 2018

1 reference

The Effects of IL-28B and ITPA polymorphisms on treatment of hepatitis C virus genotype 6.

21 January 2018

1 reference

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

PLINK: a tool set for whole-genome association and population-based linkage analyses

21 January 2018

1 reference

Twenty-four weeks of pegylated interferon plus ribavirin effectively treat patients with HCV genotype 6a.

21 January 2018

1 reference

IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infection

21 January 2018

1 reference

Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C.

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JVH.12047

1 reference

26 July 2017

1 reference